HON vs STRO
Honeywell International Inc (HON) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Honeywell International Inc (HON) is a conglomerates company listed on NASDAQ. It is led by Vimal Kapur.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported HON revenue for 2026-06-30 was $9.72B. Net income was $5.68B. Revenue was up 6.3% from 2026-03-31 to 2026-06-30. HON currently screens at market cap $144.86B and trailing P/E 36.5.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
HON currently screens at market cap $144.86B and trailing P/E 36.5. STRO currently screens at market cap $470.8M.
Not investment advice. Open the HON and STRO stock pages for the full models.
Not investment advice.